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This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Endomyocardial fibrosis [1] is usually a condition which is seen as an end-stage disease after the inflammation and thrombotic stage has passed. This patient was unique and we picked him up early. The newer imaging techniques (MRI and DOTANOC scanning) [2, 3] picked up both inflammation and a thrombus which the biopsy [4] did not pick up. Treating him aggressively helping improve a disease which has generally been considered untreatable.
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